doi: 10.1111/ijcp.13731 Summary Keywords effectiveness, GLP-1 receptor agonists, dulaglutide, once-weekly exenatide, once-weekly semaglutide, real-world evidence, type 2 diabetes mellitus Citation Di Dalmazi G, Coluzzi S, Baldassarre MPA, Ghit A, Graziano G, Rossi MC, Ciappini B, Milo M, Carrieri F, Nicolucci A, Consoli A and Formoso G (2022) Effectiveness and Tolerability of Once-Weekly GLP-1 Receptor Agonists in Clinical Practice: A Focus on Switching Between Once-Weekly Molecules in Type 2 Diabetes
Gut microbiota profiles in children and adolescents with psychiatric disorders
This information, interpreted with a qualified healthcare provider, contextualizes your individual metabolic profile within the broader science of GLP-1 therapy
Ethics declarations Competing interests J.F., R.H.Z
You are in a calorie deficit
View the verified BPC-157 range at Peptides Lab UK For research purposes only / not for human consumption